The report shows that MUC1-TRIM46-KRTCAP2 mRNA is not expressed in non-cancerous ovaries and its fusion protein localizes to cytoplasm without glycosylation in ovarian cancer cells, which is a similar feature of tumor-associated MUC1. Here, KRTCAP2 is linked to neoplasm.